dihydroethidium has been researched along with m 40403 in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (m 40403) | Trials (m 40403) | Recent Studies (post-2010) (m 40403) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 57 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyle, TM; Matuschak, GM; Muscoli, C; Ndengele, MM; Salvemini, D; Wang, ZQ | 1 |
1 other study(ies) available for dihydroethidium and m 40403
| Article | Year |
|---|---|
Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages.
Topics: Animals; Blotting, Western; Cell Nucleus; Coloring Agents; Cytokines; Cytoplasm; Endotoxins; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Escherichia coli; I-kappa B Proteins; Immunoblotting; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Lipopolysaccharides; Macrophages; Macrophages, Alveolar; Manganese; Models, Biological; NF-kappa B; NF-KappaB Inhibitor alpha; Organometallic Compounds; Oxidation-Reduction; Oxygen; Phenanthridines; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Superoxides; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2005 |